Brian D'Amore1, Sara Smolinski-Zhao2, Dania Daye2, Raul N Uppot3. 1. Drexel University College of Medicine, 2900 W Queen Lane, Philadelphia, PA, 19129, USA. 2. Division of Interventional Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street; Gray #290, Boston, MA, 02114, USA. 3. Division of Interventional Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street; Gray #290, Boston, MA, 02114, USA. uppot.raul@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to highlight the current role of machine learning and artificial intelligence and in the field of interventional oncology. RECENT FINDINGS: With advancements in technology, there is a significant amount of research regarding the application of artificial intelligence and machine learning in medicine. Interventional oncology is a field that can benefit greatly from this research through enhanced image analysis and intraprocedural guidance. These software developments can increase detection of cancers through routine screening and improve diagnostic accuracy in classifying tumors. They may also aid in selecting the most effective treatment for the patient by predicting outcomes based on a combination of both clinical and radiologic factors. Furthermore, machine learning and artificial intelligence can advance intraprocedural guidance for the interventional oncologist through more accurate needle tracking and image fusion technology. This minimizes damage to nearby healthy tissue and maximizes treatment of the tumor. While there are several exciting developments, this review also discusses limitations before incorporating machine learning and artificial intelligence in the field of interventional oncology. These include data capture and processing, lack of transparency among developers, validating models, integrating workflow, and ethical challenged. In summary, machine learning and artificial intelligence have the potential to positively impact interventional oncologists and how they provide cancer care treatments.
PURPOSE OF REVIEW: The purpose of this review is to highlight the current role of machine learning and artificial intelligence and in the field of interventional oncology. RECENT FINDINGS: With advancements in technology, there is a significant amount of research regarding the application of artificial intelligence and machine learning in medicine. Interventional oncology is a field that can benefit greatly from this research through enhanced image analysis and intraprocedural guidance. These software developments can increase detection of cancers through routine screening and improve diagnostic accuracy in classifying tumors. They may also aid in selecting the most effective treatment for the patient by predicting outcomes based on a combination of both clinical and radiologic factors. Furthermore, machine learning and artificial intelligence can advance intraprocedural guidance for the interventional oncologist through more accurate needle tracking and image fusion technology. This minimizes damage to nearby healthy tissue and maximizes treatment of the tumor. While there are several exciting developments, this review also discusses limitations before incorporating machine learning and artificial intelligence in the field of interventional oncology. These include data capture and processing, lack of transparency among developers, validating models, integrating workflow, and ethical challenged. In summary, machine learning and artificial intelligence have the potential to positively impact interventional oncologists and how they provide cancer care treatments.
Authors: Christopher C Riedl; Nikolaus Luft; Clemens Bernhart; Michael Weber; Maria Bernathova; Muy-Kheng M Tea; Margaretha Rudas; Christian F Singer; Thomas H Helbich Journal: J Clin Oncol Date: 2015-02-23 Impact factor: 44.544
Authors: Anton S Becker; Michael Mueller; Elina Stoffel; Magda Marcon; Soleen Ghafoor; Andreas Boss Journal: Br J Radiol Date: 2018-01-10 Impact factor: 3.039
Authors: Martin J Willemink; Wojciech A Koszek; Cailin Hardell; Jie Wu; Dominik Fleischmann; Hugh Harvey; Les R Folio; Ronald M Summers; Daniel L Rubin; Matthew P Lungren Journal: Radiology Date: 2020-02-18 Impact factor: 11.105